GlaxoSmithKline and Adolor Present Positive Results from a Clinical Study of Alvimopan (Entereg(R))
GlaxoSmithKline and Adolor Present Positive Results from a Clinical Study of Alvimopan (Entereg(R))
GlaxoSmithKline ( Nachrichten / Aktienkurs ) (LSE and NYSE:GSK) and Adolor Corporation ( Nachrichten ) (NASDAQ:ADLR) today presented at the American Pain Society Meeting in San Antonio, Texas, positive results from a Phase 2b clinical study of alvimopan (Entereg), an orally administered investigational drug that blocks peripheral mu-opioid receptors.(1) In this large study, evaluating alvimopan
Integrating medicine with healthy living
The Wellness Teaching Center has massage therapists to rub you the right way and a chiropractor to work out the more serious kinks.
Happy feet
For years, it seemed like nothing would alleviate Sarah Faymans chronic back pain.
Health Calendar
Hy-Vee Healthy Heart Tours . Take an aisle-by-aisle tour to learn how to better control blood lipid levels, 10 a.m. Friday, May 12, Hy-Vee, 1823 E. Kimberly Road, Davenport.
For people with fibromyalgia, its not really all in their head
Fibromyalgia is all in ones head but its not what you think, said Dr. Carol Danning. The common chronic condition, characterized by fatigue and widespread body pain, is a problem to control, said Danning, a Gundersen Lutheran rheumatologist.